AIDS and Behavior

, Volume 15, Issue 1, pp 65–74 | Cite as

Correlates of HIV Risk Among Injecting Drug Users in Sixteen Ukrainian Cities

  • Yuriy S. Taran
  • Lisa G. Johnston
  • Nataliia B. Pohorila
  • Tetiana O. Saliuk
Original Paper

Abstract

We present findings from a HIV survey using respondent driven sampling among 3,711 injecting drug users (IDUs) in 16 cities in Ukraine in 2008. Eligible participants were males and females who injected drugs in the past 1 month, ≥16 years and lived/worked in their respective interview area. The impact of injecting and sexual risk behaviors on HIV-infection were analyzed using four logistic models. Overall HIV prevalence was 32%. In the sexual risk model, paying for sex in the past 3 months and condom use during last sex increased the odds of HIV infection. Being female, having greater than 3 years of injection drug use, always sharing equipment and using alcohol with drugs in the past month remained significant in all four models. These findings indicate the urgent need to scale up peer education, needle exchange and methadone substitution programs for IDUs with specific programs targeting the needs of female injectors

Keywords

Ukraine HIV/AIDS Injecting drug users Sexual risk behaviors Respondent driven sampling 

References

  1. 1.
    Wessing L, Van de Laar MJ, Donoghoe MC, Guarita B, Klempova D, Griffiths P. HIV among injection drug users in Europe: increasing trends in the East. Eurosurveillance. 2008;13(50). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19067. Accessed 21 September 2010.
  2. 2.
    Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP. The most severe HIV epidemic in Europe: Ukraine’s national HIV prevalence estimates for 2007. Sex Transm Infect. 2008;84:137–41.CrossRefGoogle Scholar
  3. 3.
    National AIDS Prevention Centre/Ministry of Health. HIV infection in Ukraine in 2008. Information bulletin No 31. Kyiv, Ukraine. 2009. http://www.aidsalliance.org.ua/ru/library/research/pdf/bulleten31en.pdf. Accessed 21 September 2010.
  4. 4.
    Ministry of Health of Ukraine. Ukraine: national report on monitoring progress towards the UNGASS declaration of commitment on HIV/AIDS. Reporting period: January 2006–December 2007. Kyiv, Ukraine. 2008. http://data.unaids.org/pub/Report/2008/ukraine_2008_country_progress_report_en.pdf. Accessed 21 September 2010.
  5. 5.
    Barnett T, Whiteside A, Kruglov Y, Steshenko V, Khodakevich L. The HIV/AIDS epidemic in Ukraine: its potential social and economic impact. Soc Sci Med. 2000;51(9):1387–403.CrossRefPubMedGoogle Scholar
  6. 6.
    International HIV/AIDS Alliance. Estimation of the size of most at risk populations for HIV-injection drug users, female sex workers, men who have sex with men. Kyiv, Ukraine. 2009.Google Scholar
  7. 7.
    International HIV/AIDS Alliance. Results from the study on seroconvertor behaviour. Unpublished data. Kyiv, Ukraine. 2007.Google Scholar
  8. 8.
    Booth RE, Kennedy J, Brewster T, Semerik O. Drug injectors and dealers in Odessa, Ukraine. J Psychoactive Drugs. 2003;35(4):419–26.PubMedGoogle Scholar
  9. 9.
    Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvorak S. Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS. 2006;20:2217–33.CrossRefPubMedGoogle Scholar
  10. 10.
    Chintalova-Dallas R, Case P, Kitsenko N, Lazzarini Z. Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine. Int J Drug Policy. 2009;20(4):347–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Booth RE, Lehman WEK, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Stimulant injectors in Ukraine: the next wave of the epidemic. AIDS Behav. 2008;12:652–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Dumchev KV, Soldyshev R, Han-Zhu Qian, Zezyulin OO, Chandler SD, Slobodyanyuk P, Moroz L, Schumacher JE. HIV and hepatitis C virus infections among Hanka injection drug users in Central Ukraine: a cross-sectional survey. Harm Reduct J. 2009;6:23. Available from: http://harmreductionjournal.com/content/pdf/1477-7517-6-23.pdf.
  13. 13.
    Booth RE, Lehman WEK, Brewster JT, Sinitsyna L, Dvoryak S. Gender differences in sex risk behaviors among Ukraine injecting drug users. J Acquir Immune Defic Syndr. 2007;46(1):112–7.PubMedGoogle Scholar
  14. 14.
    Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Semerik O. Predictors of self-reported HIV infection among drug injectors in Ukraine. J Acquir Immune Defic Syndr. 2004;35(1):82–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Heckathorn D. Respondent driven sampling II: deriving valid population estimates from Chain referral samples of hidden populations. Social Problems. 2002;49(1):11–34.CrossRefGoogle Scholar
  16. 16.
    Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent driven sampling. Sociol Methodol. 2004;34:193–239.CrossRefGoogle Scholar
  17. 17.
    Behavioral surveillance surveys: guidelines for repeated behavioral surveys in populations at risk of HIV. Available from http://www.fhi.org/en/HIVAIDS/pub/guide/bssguidelines.htm. Accessed 21 September 2010.
  18. 18.
    Monitoring the declaration of commitment on HIV/AIDS. Guidelines on construction of core indicators. UNAIDS, March 2007. Available from http://data.unaids.org/pub/Manual/2009/JC1676_Core_Indicators_2009_en.pdf. Accessed 21 September 2010.
  19. 19.
    Benyo A. Promoting secondary exchange: opportunities to advance public health. The Harm Reduction Coalition, Syringe Access Expansion Project. New York, 2006. http://www.harmreduction.org/downloads/fact%20sheet%20secondaryx.pdf. Accessed 5 June 2010.
  20. 20.
    Webb CM, Bromet EJ, Gluzman S, Tintle NI, Schwartz JE, Kostyuchenko S, Havenaar JM. Epidemiology of heavy alcohol use in Ukraine: findings from the world mental health survey. Alcohol Alcoholism. 2005;40(4):327–35.CrossRefGoogle Scholar
  21. 21.
    Bellis MA, Hughes K, Calafat A, Juan M, Ramon A, Rodriguez JA, Mendes F, Schnitzer S, Phillips-Howard P. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities. BMC Public Health. 2008;8:155 doi: 10.1186/1471-2458-8-155.
  22. 22.
    Booth R, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risk among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alc Dep. 2000;58:219–26.CrossRefGoogle Scholar
  23. 23.
    Stein MD, Anderson B, Chatuvasta A, et al. Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange. Alcoholism: Clin Exp Res. 2001;25:1487–93.CrossRefGoogle Scholar
  24. 24.
    United Nations Office of Drug Control. HIV/AIDS prevention and care for female injecting drug users. 2006. Available http://www.unodc.org/documents/hiv-aids/publications/HIV-AIDS_femaleIDUs_Aug06.pdf. Accessed 21 September 2010.
  25. 25.
    Pohorila NB, Shamota AZ. Izuchenie rasprostranennosti VICH i povedenia riska v gruppe PIN, otsenka chislennosti PIN v Moskve [The study of HIV-prevalence and risk behavior within IDUs; number estimation of IDUs in Moscow]. The report for the global fund for HIV, tuberculosis and malaria prevention. Unpublished data. Moscow: “ESVERO”. 2010.Google Scholar
  26. 26.
    European Monitoring Centre for Drugs and Drug Addiction. Statistical bulletin, Lisbon, Portugal. 2007. Available from http://www.emcdda.europa.eu/html.cfm/index39756EN.html. Accessed 21 September 2010.
  27. 27.
    Des Jarlais DC, Perlis T, Stimson G, Poznyak V, The WHO Phase II Drug Injection Collaborative Study Group. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II. BMC Public Health. 2006;6:54.CrossRefPubMedGoogle Scholar
  28. 28.
    Cleland CM, Des Jarlais DC, Perlis TE, Stimson G, Poznyak V, The WHO Phase II Drug Injection Collaborative Study Group. HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health. 2007;7:271.CrossRefPubMedGoogle Scholar
  29. 29.
    International HIV/Alliance. HIV/AIDS: gender prospective. HIV/AIDS Newsletter. 2006. Available from http://www.aidsalliance.org.ua/cgi-bin/index.cgi?url=/en/library/our/aidsnws/index.htm. Accessed 21 September 2010.
  30. 30.
    Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, Hughes J. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(Suppl 1):42–57.PubMedGoogle Scholar
  31. 31.
    Booth RE, Lehman WEK, Latkin CA, Dvoryak S, Brewster JT, Royer MS, Sinitsyna L. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 10.2105/AJPH.2009.172304 E-pub ahead of print April 15, 2010.

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Yuriy S. Taran
    • 1
  • Lisa G. Johnston
    • 2
    • 3
  • Nataliia B. Pohorila
    • 3
  • Tetiana O. Saliuk
    • 3
  1. 1.Graduate School for Social ResearchWarsawPoland
  2. 2.Department of International Health & DevelopmentTulane University School of Public Health & Tropical MedicineNew OrleansUSA
  3. 3.ICF International HIV/AIDS Alliance in UkraineKyivUkraine

Personalised recommendations